Researchers at Heidelberg University Hospital Develop First Marketable Blood Test for Breast Cancer
Diagnosis based on a combination of biomarkers / Gentle procedure for patients / Test provides further data on the tumour / CE certification started / Market launch by HeiScreen GmbH planned for this year / Cohort studies at Heidelberg University Hospital provide the basis
Prof. Dr. Sarah Schott and Prof. Dr. Christof Sohn from the Heidelberg University Hospital. Photo: University Hospital Heidelberg
Read full article (in German).